Aortic Valve Disorder Clinical Trial
Official title:
Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage
Atrial fibrillation (AF) is a common comorbidity of patients candidates to transcatheter aortic valve implantation (TAVI). The management of chronic oral anticoagulation (OAC) for the prevention of ischemic stroke is very challenging in this population of complex and frail subjects. Since the percutaneous left atrial appendage (LAA) closure with the WATCHMAN device proved promising safety and efficacy results in randomized comparisons with OAC (current standard of care), the aim of the current study is to assess the feasibility and the early safety of performing TAVI with the Lotus System and percutaneous LAA closure with the WATCHMAN device at the same session.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02910349 -
Novel Cardiac Imaging Prognostic Markers of Clinical Outcome in Patients With Chronic Aortic Regurgitation
|
||
Completed |
NCT03298932 -
2D Strain of Right Ventricle in Peroperative of Cardiac Surgery
|
||
Completed |
NCT01171625 -
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
|
N/A | |
Completed |
NCT01959503 -
Progel Vascular Sealant
|
N/A | |
Completed |
NCT01353287 -
Transcatheter Aortic Valve Intervention-Live Transmission
|
N/A | |
Completed |
NCT03016169 -
Trifectaâ„¢ GT Post Market Clinical Follow-up
|
N/A | |
Suspended |
NCT01536717 -
Comparison of the Local Anaesthetics Articaine and Bupivacaine in Treatment of Acute Sternum Pain After Heart Surgery
|
Phase 4 | |
Completed |
NCT00934596 -
CO2 Versus Lund De-airing Technique in Heart Surgery
|
N/A | |
Completed |
NCT01651052 -
Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000
|
N/A | |
Terminated |
NCT02696226 -
Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.
|
N/A | |
Completed |
NCT01619982 -
Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients
|
Phase 4 |